The Online Investor
Home
Dividends
25 Safe Dividends
Stock Splits
Mergers & Acquisitions
Business Services/Equipment M&A

Construction M&A
   General Contractors & Builders M&A
Consumer Goods M&A
   Sporting Goods & Activities M&A
   Office Supplies M&A
   Food & Beverage M&A
   Beverages & Wineries M&A
   Cigarettes & Tobacco M&A
   Marijuana Stocks M&A
   Apparel Stores M&A
   Department Stores M&A
   Grocery & Drug Stores M&A
   Electronics Stores M&A
   Home Improvement Stores M&A
   Home Furnishing Stores M&A
   Auto Dealerships M&A
   Specialty Retail M&A
Consumer Services M&A
   Education & Training Services M&A
Energy M&A
   Oil & Gas Refining & Marketing M&A
   Oil & Gas Exploration & Production M&A
   Oil & Gas Equipment & Services M&A
Financial M&A
   Banking & Savings M&A
   Investment Brokerages M&A
   Investment Companies & Venture Capital M&A
   Asset Management M&A
   Credit Services & Lending M&A
   Life & Health Insurance M&A
   Insurance Brokers M&A
Healthcare M&A
   Drugs & Pharmaceuticals M&A
   Biotechnology M&A
   Diagnostics M&A
   Medical Instruments & Supplies M&A
   Hospital & Medical Practitioners M&A
Industrial M&A
   Chemicals M&A
   Specialty Chemicals M&A
   Defense M&A
   Aerospace & Defense M&A
   Construction Materials & Machinery M&A
   Industrial Machinery & Equipment M&A
Manufacturing M&A
   Home Furnishings & Furniture M&A
   Auto Manufacturers M&A
   Auto Parts M&A
   Textiles & Apparel M&A
Materials M&A
   Agricultural Chemicals M&A
   Rubber & Plastics M&A
   Paper & Forest Products M&A
   Packaging & Containers M&A
   Agriculture & Farm Products M&A
Media M&A
   Advertising M&A
   Television & Radio M&A
   Publishing & Printing M&A
Metals & Mining M&A
   Precious Metals M&A
   Non-Precious Metals & Non-Metallic Mining M&A
   Metals Fabrication & Products M&A
Real Estate M&A
   REITs M&A
Technology M&A
   Electronic Equipment & Products M&A
   3D Printing Stocks M&A
   Computers M&A
   Computer Peripherals M&A
   Application Software M&A
   Semiconductors M&A
   Information Technology Services M&A
Transportation M&A
   Air Services Other M&A
   Airlines M&A
   Trucking M&A
   Shipping M&A
   Railroads M&A
Travel & Entertainment M&A
   Hotels, Lodging, Restaurants & Travel M&A
   Entertainment M&A
Utilities M&A
   Waste Management M&A
   Communications Services M&A
   Electric Utilities M&A
   Gas Utilities M&A
   Water Utilities M&A
Mega Mergers
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Stock Buybacks
IPOs
Secondary Offerings
Top 20 Large Caps
Top 20 Biggest ETFs
Insider Buying
Top 25 Low PE Ratios
Analyst Actions
25 Top Analyst Picks
Articles
CAGR Calculator
Dunnan On Dollars
10 Pot Stocks
ETF Center
Knowledge Center
Retirement Center
Advertising Opportunities
Privacy Policy
Disclaimer Statement
Drugs & Pharmaceuticals M&A image Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Thu., Apr. 18, 7:04 PM Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.

This Slide: #31 of 100

Slide #31. Imprimis Pharmaceuticals — Pharmacy Creations

Acquirer: Imprimis Pharmaceuticals (IMMY)
Acquiree: Pharmacy Creations
Details: Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary and novel sterile and topical drug formulations, today announced that it has come to an agreement to acquire Pharmacy Creations LLC (www.pharmacycreations.com), a premier, state-of-the-art compounding pharmacy located in Randolph, New Jersey. This acquisition would permit the Company to make and distribute its patent-pending proprietary drug formulations and other novel pharmaceutical solutions.

Imprimis Pharmaceuticals is an ophthalmology-focused pharmaceutical company focused on the development, production and sale of medications. Co. operates its business through several subsidiaries: ImprimisRx, an ophthalmology focused compounding business; Park Compounding, a custom compounding business focused on patient specific orders; and Surface Pharmaceuticals, Inc., an ocular surface disease-focused 505(b)(2) specialty pharmaceutical subsidiary.

Open the IMMY Page at The Online Investor »

IMMY — Key Stats (updated Thu., Jan. 3, 10:20 AM)
Company Name:  Harrow Health Inc
Website:  www.imprimispharma.com
Sector:  Drugs & Pharmaceuticals
 

Open the IMMY Page at The Online Investor (in a new window) »
April 18, 2024  •  7:04 PM Eastern
IMMY — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree IMMY Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Avg. Broker Rec.

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Drugs & Pharmaceuticals M&A - Slide 31 of 100 | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.